Sisseton, SD, United States of America

James M Schiltz

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Avianax, LLC. Active years: 2011-2014.

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2011-2014

Loading Chart...
2 patents (USPTO):Explore Patents

Title: James M Schiltz: Innovator in Therapeutic Antibodies

Introduction

James M Schiltz is a notable inventor based in Sisseton, SD (US). He has made significant contributions to the field of therapeutic antibodies, particularly in the treatment and prevention of transmittable viral diseases. With a total of 2 patents, Schiltz's work has the potential to impact both avian and mammalian health.

Latest Patents

Schiltz's latest patents focus on therapeutic antibodies for the treatment and prophylaxis of transmittable viral diseases. The inventions provide methods and compositions that utilize avian antibodies to combat these diseases. Administration of these avian antibodies has been shown to effectively reduce mortality rates in infected populations. Additionally, the patents include kits designed for detecting the presence of transmittable diseases in subjects.

Career Highlights

James M Schiltz is associated with Avianax, LLC, where he continues to develop innovative solutions in the field of viral disease treatment. His work emphasizes the importance of utilizing avian antibodies, showcasing a unique approach to addressing health challenges.

Collaborations

Schiltz collaborates with notable colleagues, including Marshall K Brinton and James K Petell. Their combined expertise contributes to the advancement of research and development in therapeutic applications.

Conclusion

James M Schiltz stands out as an inventor dedicated to improving health outcomes through innovative therapeutic solutions. His contributions to the field of transmittable viral diseases highlight the importance of research and collaboration in driving advancements in medical science.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…